MedTrace Logo

Evaluation of Inhaled Treatment in Sinusitis

NCT01907204 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-01-27

No results posted yet for this study

Summary

The purpose of this study is to determine whether inhaled corticosteroid (specially nebulized) could be a good alternative to oral corticosteroid and whether they are effective in the treatment of sinusitis

Conditions

  • Sinusitis

Interventions

DRUG

methylprednisolone

Oral 32mg/8d-16mg/4d-8mg/4d

DRUG

Budesonide

Budesonide by metered dose inhaler

DRUG

Budesonide

Budesonide by nebulization

Sponsors & Collaborators

  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    lead OTHER

Principal Investigators

  • Gregory Reychler, PhD · Cliniques universitaires Saint-Luc- Université Catholique de Louvain

  • Philippe Rombaux, Prof PhD · Cliniques universitaires Saint-Luc- Université Catholique de Louvain

  • Coralie Colbrant, PT · Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-08-31
Completion
2014-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01907204 on ClinicalTrials.gov